01/06/2026
Cholesterol & Lipoprotein Comparison85oro
10/10/23 → 12/18/25
Marker 10/10/23 (Baseline) 12/18/25 (Current) Change
Total Cholesterol 281 mg/dL 219 mg/dL ⬇️ −62 mg/dL
Triglycerides 161 mg/dL 152 mg/dL ⬇️ −9 mg/dL
HDL Cholesterol 46 mg/dL 53 mg/dL ⬆️ +7 mg/dL
LDL-C (calculated) 205 mg/dL 139 mg/dL ⬇️ −66 mg/dL
Non-HDL Cholesterol 235 mg/dL 166 mg/dL* ⬇️ −69 mg/dL
Apolipoprotein B (ApoB) 172 mg/dL 114 mg/dL ⬇️ −58 mg/dL
Lp(a) Not measured 6.5 mg/dL Excellent (low risk)
*Non-HDL 12/18/25 calculated as Total Cholesterol − HDL (219 − 53).
Sources:
* 10/10/23 LabCorp lipid panel & ApoB 10:10:23�
* 12/18/25 Access Medical Labs lipid panel, ApoB, Lp(a) Gary bloodwork 12:18:25�
How to Interpret This (Patient-Education Friendly)
🔹 What improved the most
* LDL-C down 32%
* ApoB down 34%
* Non-HDL cholesterol down ~29%
* HDL increased
👉 These changes mean fewer atherogenic (artery-damaging) particles, not just a cosmetic cholesterol drop.
🔹 Why ApoB matters most
* ApoB represents the number of cholesterol-carrying particles
* Cardiovascular risk tracks more closely with ApoB than LDL alone
* Dropping from 172 → 114 mg/dL is a major risk reduction
🔹 Big picture
From 10/10/23 to 12/18/25, your cholesterol profile shifted from:
Very high atherogenic risk → substantially lower particle burden
This aligns with your documented improvements in insulin resistance, which is a primary driver of abnormal cholesterol patterns.
📉 Cholesterol Didn’t Improve by Accident.
On 10/10/23, my labs showed:�• Total Cholesterol: 281�• LDL: 205�• ApoB (particle count): 172
That’s a high cardiovascular risk profile, even with “normal” blood sugar.
After 90 days using the product and focusing on metabolic health, my 12/18/25 labs showed:�• Total Cholesterol: 219�• LDL: 139�• ApoB: 114�• HDL improved
📊 30–35% reduction in atherogenic particles — in just 90 days.
The lesson?�Cholesterol issues usually aren’t about cholesterol first — they’re about insulin and metabolism.
Fix the root, and the numbers follow.
